Pharmacy Insight Report

Beyond Dispensing: What Is Holding Pharmacists Back?

A peer-level look at a profession asked to deliver more clinical care while the operating system still rewards speed, product flow, shortage management, and fragmented work. The role has evolved. The question is whether the infrastructure around it has.

Healthcare professionals:  204 responses

Complete responses: 159

Countries: 6

Survey ID: 8881721

-headline finding

0 %
still spend most of the shift in production-dominant or production-weighted workflows, even as pharmacists are expected to deliver more patient-facing clinical care.
identify staffing or remuneration as the main barrier to expanded clinical services
0 %
say throughput metrics or incomplete records compromise clinical evaluation
0 %
spend more than two hours each week managing medicine shortages
0 %
choose bidirectional health-record interoperability as the most immediate technology relief
0 %

–  Quick Read — Key Findings

Read the full MDForLives insight report

Explore the complete story, every closed-question response, peer-voice themes, practice implications, and external context.

//Background and Methodology

Why we asked pharmacists about clinical transformation now

The pharmacist visible to patients is increasingly a clinician: administering vaccines, conducting screening and point-of-care testing, reviewing complex therapies, supporting chronic disease management, and resolving medication-safety risks. WHO/Europe has documented this expansion beyond traditional supply and dispensing as a way to improve patient care and reduce pressure on other health professionals.

 

The Agency for Healthcare Research and Quality describes pharmacists as central to medication safety across the care continuum, including recognizing prescription errors, providing medicine information, and leading safety programs. Yet the operating system around this clinical role still measures product movement more reliably than cognitive work.

 

This creates a structural mismatch. New clinical services are added to the same shift, often without removing production tasks, protecting consultation time, integrating records, or creating reliable payment for clinical judgment. Scope expands, but capacity is expected to appear on its own.

 

We asked practicing pharmacists across six countries to trace that mismatch through the full workflow: time allocation, remuneration, medication reviews, performance metrics, medicine shortages, education, collaboration, and technology. The curiosity is not whether pharmacists can provide more care. It is what must stop consuming the time, information, and economic space required to do it safely.

Pharmacy has moved beyond dispensing in responsibility, but not yet in the way time, information, and value are organized.
MDForLives Research Interpretation

// Core Finding

The operating-model paradox: clinical responsibility is growing faster than the system that supports it

58.8% remain in production-dominant or production-weighted workflows, while 68.1% identify labor deficits or remuneration asymmetry as the main barrier to expanded clinical services. The profession is not waiting to become clinical. It is already carrying clinical responsibility inside a model that has not released the time or economics of production.

identify staffing or remuneration as the main barrier to expanded clinical services
0 %
say throughput metrics or incomplete records compromise clinical evaluation
0 %
spend more than two hours each week managing medicine shortages
0 %
choose bidirectional health-record interoperability as the most immediate technology relief
0 %

//The backstory behind the operating-model gap

The clinical role expanded by addition, not redesign

The transformation of pharmacy has often happened by layering new services onto an old production engine. Vaccination, testing, consultation, prescribing, safety review, and chronic-care support arrive as additional responsibilities, while dispensing queues, verification targets, inventory work, and shortage substitutions remain.

 

That is why the findings connect. A production-weighted shift limits clinical time. Limited clinical time makes service expansion dependent on staffing. Unpaid cognitive work weakens the business case for protected care. Throughput metrics compete with review quality. Missing records narrow judgment. Shortages redirect the same pharmacist time the system wants to use for patient care.

//Workflow and remuneration

Why expanded scope does not automatically create clinical capacity

The largest barriers are staffing shortages and the absence of standardized payment for cognitive services. Permission to provide care is not enough when the shift remains built around production.

The medication review is squeezed by speed and missing information

Throughput-driven metrics and incomplete patient records together account for 64.0% of the factors most compromising clinical evaluation.

//Operational drag

The shortage tax is consuming the same clinical time the system wants to expand

83.2% spend more than two hours each week managing shortages, and almost one third spend six hours or more. The US Food and Drug Administration notes that drug shortages can arise from manufacturing and quality problems, production delays, and product discontinuations. Whatever the upstream cause, the downstream coordination burden lands inside pharmacy workflow.

//Technology and sustainability

Why pharmacists want shared records before more automation

50.6% prioritize bidirectional EHR interoperability. For long-term sustainability, payment reform and stronger oversight of intermediaries outrank a fully automated consultant model.

// Methodology and Context

How the findings were interpreted

The survey captured 204 responses, including 159 complete and 45 partial responses, across six countries. Question-level bases vary because partial responses were included before later questions. Percentages and response counts in the backend section are reproduced exactly from the source export.

// at a glance
Total Survey Records
204
Countries Covered
6
Specialty
Pharmacists
Published Date
24 June 2026
Completion Rate
77.9%
Survey ID
8881721
// browse categories

You have read the summary

Go deeper into the findings.
Be part of what comes next.

Explore the complete findings in the full report, or join MDForLives to contribute your perspectives to future healthcare research.

//People Also Ask

Frequently asked questions about the evolving role of pharmacists

Direct answers to the questions healthcare professionals are most likely to ask about these findings.

Is pharmacy practice really becoming more clinical?

The transition is visible but incomplete. 28.5% described their workflow as clinical-dominant, while 58.8% still spent most of the shift in production-dominant or production-weighted work.

Labor deficits were the leading barrier at 36.2%, followed by the lack of standardized payment for cognitive clinical services at 31.9%. Together, these barriers represented 68.1% of responses.

Throughput-driven performance metrics led at 32.3%, closely followed by incomplete patient records at 31.7%. Pharmacists therefore need both protected clinical time and access to complete clinical information.

83.2% spent more than two hours each week managing shortages. 31.9% spent six hours or more sourcing alternatives, resolving inventory gaps, and coordinating therapeutic substitutions.

Bidirectional electronic health record access was the leading technology priority, selected by 50.6%. It ranked ahead of automated prescription verification, centralized fulfillment, and predictive supply-chain tools.

Stronger oversight of pharmacy middlemen ranked first at 32.7%, followed by separating pharmacist remuneration from physical product sales at 27.7%. The findings place economic reform at the center of clinical transformation.

Related Reports

Direct answers to the questions healthcare professionals are most likely to ask about these findings.

Scroll to Top